Therapeutic potential of targeting IL-17.
A June 2012 meeting in Dublin, Ireland, showcased advances in the understanding of the role of IL-17 and related cytokines in host immunity and how these cytokines have been successfully targeted for the treatment of autoimmunity.
School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
Sarah A
SA
Jones
Caroline E
CE
Sutton
Daniel
D
Cua
Kingston H G
KH
Mills
D056704:Adaptive Immunity / Q000187:drug effects; D000818:Animals; D000906:Antibodies / Q000627:therapeutic use; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy; D015551:Autoimmunity / Q000187:drug effects; D001424:Bacterial Infections / Q000276:immunology / Q000628:therapy; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects; D007155:Immunologic Factors / Q000627:therapeutic use*; D020381:Interleukin-17 / Q000037:antagonists & inhibitors / Q000276:immunology*; D051379:Mice; D058990:Molecular Targeted Therapy; D009181:Mycoses / Q000276:immunology / Q000628:therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy; D053722:Receptors, Interleukin-17 / Q000037:antagonists & inhibitors / Q000276:immunology*; D058504:Th17 Cells / Q000187:drug effects / Q000276:immunology; D014777:Virus Diseases / Q000276:immunology / Q000628:therapy
D000906:Antibodies; D007155:Immunologic Factors; D020381:Interleukin-17; D053722:Receptors, Interleukin-17